Gene therapy, surgery could mean eight more months for sickest brain cancer patients

As the most malignant of primary brain cancers, glioblastomas are frustratingly difficult to treat. Surgery is often risky and cannot remove all of the tumor, and chemotherapy eventually becomes ineffective for most patients. Median survival is around 15 months for patients with this tumor, and the quality of life in the last five months is often quite poor.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1Jh34yz